Abstract:Best Oral Presentation
ContentsObjective: Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL-ACT) is a promising immunotherapy using autologous lymphocytes ex vivo expanded from patient's tumor. We are performing a phase I study for malignant melanoma and then perform a phase II study for recurrent cervical cancer as to evaluate the safety and efficacy of TIL-ACT. Methods: Three patients with malignant melanoma received TIL-ACT. Tumor fragments were cultured in outgrowth medium to produce TIL. The… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.